Market News & Trends
FDA Grants Advanced Manufacturing Technology Designation to AustinPx’s KinetiSol Platform
AustinPx has received Advanced Manufacturing Technology (AMT) designation from the U.S. Food and Drug Administration (FDA) for its KinetiSol™ Technology, a solvent-free manufacturing process designed…
Vetter Adds New Commercial Manufacturing Capacity as Global Network Expands
Vetter is expanding its global commercial manufacturing footprint as part of a long-term investment program aimed at increasing fill-and-finish capacity and providing pharmaceutical and biotechnology…
Lonza Capsugel Introduces Integrated Approach to Nitrosamine Risk Assessment
Pharmaceutical manufacturers evaluating potential nitrosamine formation in drug products can now access nitrite testing and related scientific and regulatory support through a new integrated service…
Schreiner MediPharm Introduces Multifunctional Security Label for GLP-1 Pens and Autoinjectors
As demand for injectable GLP-1 therapies continues to expand, pharmaceutical manufacturers are facing increased requirements for product authentication, tamper evidence, usability, and supply-chain visibility. Schreiner…
Recipharm, CanVirex Advance Manufacturing Development for Oncolytic Measles Virus Therapy
Recipharm and Swiss biotechnology company CanVirex are collaborating to develop a scalable manufacturing process for an oncolytic measles virus candidate being developed for the treatment…
Eli Lilly Breaks Ground on $6.5B Houston API Facility to Scale Oral GLP-1 and Genetic Medicines
Eli Lilly and Company has officially broken ground on a massive $6.5 billion active pharmaceutical ingredient (API) manufacturing campus in Houston, Texas. The facility marks…
Magnitude Biosciences Secures $1.72M to Scale C. elegans High-Throughput In Vivo Screening Platform
Contract research organization and Durham University spinout Magnitude Biosciences has closed a $1.72 million investment round to accelerate the commercial scale-up of its flagship in…
SCHOTT Pharma and Nemera Co-Develop Integrated 5.5 mL Syringe and Safety Platform to Advance At-Home Biologic Delivery
As biopharma accelerates the transition from hospital-based intravenous (IV) infusions to at-home subcutaneous administration, containment and delivery specialists SCHOTT Pharma and Nemera have partnered to…
Bespak, Upperton Team Up on Integrated Nasal Drug Product Development
Bespak and Upperton are combining their respective drug-development capabilities in a new collaboration aimed at helping pharmaceutical companies move nasal drug products from early formulation…
Kincell Bio, Cellipont Bioservices Complete Merger to Create Kincellis Advanced Therapies
Kincell Bio and Cellipont Bioservices have completed their previously announced merger, bringing the two advanced-therapy organizations together under a new company, Kincellis Advanced Therapies. The…
AI Algorithm Guides Modified-Release Tablet Design in Ongoing Clinical Study
An artificial intelligence algorithm has selected modified-release tablet formulations and dose levels during an ongoing clinical study, according to interim findings reported by Quotient Sciences.…
Upperton Secures MHRA Approval for New Sterile Manufacturing Facility
CDMO Upperton Pharma Solutions has received approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to begin GMP manufacture of sterile investigational medicinal…
New Hovione Facility Expands U.S. Capacity for Poorly Soluble Drug Development
CDMO Hovione has opened a new 31,000-square-foot facility at its East Windsor, New Jersey campus, doubling its US spray drying capacity as the company expands…
RSSL Launches Pharmaceutical Consultancy Service to Support Complex Drug Development and Manufacturing Challenges
Reading Scientific Services Ltd (RSSL) has launched a dedicated pharmaceutical consultancy offering aimed at helping pharmaceutical, biopharmaceutical and advanced therapy companies address increasingly complex challenges…
Zeteo Biomedical Takes Active Powder Delivery Platform Into Pulmonary Market
Zeteo Biomedical is moving beyond nasal drug delivery and into pulmonary applications with AriesMR, a reloadable dry powder inhaler intended to actively disperse pharmaceutical powders…
AI Failures Cost Life Sciences Organizations Millions as Process Gaps Persist
Artificial Intelligence adoption is accelerating across the healthcare and life sciences sectors, but poorly designed processes are emerging as a major obstacle to successful implementation,…
Ecolab Adds Resin Manufacturing Capacity With New Quzhou Facility
Ecolab is expanding its manufacturing and R&D footprint in China with the opening of a new resin production facility in Quzhou, a move aimed at…
Novo Nordisk Launches ‘Novo’ Rebrand to Sharpen Global Identity
Novo Nordisk is repositioning its corporate identity as it prepares for what the company describes as its next chapter, introducing a new brand platform, adopting…
BioLife Wins US Patent for Effervescent Oral Peptide Delivery Platform
BioLife has received a US patent for an effervescent tablet technology intended to enable oral delivery of peptide therapeutics, including GLP-1 receptor agonists used in…
AbbVie Strengthens Dermatology and Respiratory Pipeline With Apogee Acquisition
AbbVie has completed its acquisition of Apogee Therapeutics, adding a portfolio of long-acting antibody programs to its immunology and inflammation pipeline as the pharmaceutical company…
